Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neuronal PAS domain protein 4 (NPAS4) is an activity-dependent transcription factor belonging to the basic helix-loop-helix-PER-ARNT-SIM (bHLH-PAS) family, encoded by the NPAS4 gene. It is rapidly induced in neurons following synaptic activity and plays a key role in regulating the transcription of genes that control inhibitory synapse development, synaptic plasticity, and the excitatory–inhibitory (E/I) balance critical for neural circuit function. NPAS4 acts mainly in the brain and forms heterodimers with ARNT and ARNT2, enabling it to bind DNA and modulate the expression of target genes such as BDNF. Dysregulation or loss of NPAS4 function is implicated in various central nervous system illnesses, including epilepsy, neuropsychiatric, and metabolic diseases. Structural analyses reveal its PAS domains possess ligand-accessible pockets, presenting potential opportunities for therapeutic targeting, although no approved drugs directly target this molecule at present.
Not established in the clinic; potential mechanisms would involve small molecules modulating NPAS4 dimerization, transcriptional activity, or activity-dependent gene regulation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neuronal PAS domain protein 4 (NPAS4).